Alimera Sciences Inc ALIM:NASDAQ

RT Quote | NASDAQ | USD
Last | 09/30/22 EDT
5.08quote price arrow down-0.17 (-3.24%)
Volume
4,833
52 week range
3.94 - 7.92
Loading...
  • Open5.15
  • Day High5.20
  • Day Low5.08
  • Prev Close5.25
  • 52 Week High7.92
  • 52 Week High Date08/03/22
  • 52 Week Low3.94
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap35.56M
  • Shares Out7.00M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta1.39
  • YTD % Change-0.97

KEY STATS

  • Open5.15
  • Day High5.20
  • Day Low5.08
  • Prev Close5.25
  • 52 Week High7.92
  • 52 Week High Date08/03/22
  • 52 Week Low3.94
  • 52 Week Low Date05/12/22
  • Market Cap35.56M
  • Shares Out7.00M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta1.39
  • YTD % Change-0.97

RATIOS/PROFITABILITY

  • EPS (TTM)-2.49
  • P/E (TTM)-2.04
  • Fwd P/E (NTM)-3.91
  • EBITDA (TTM)-8.228M
  • ROE (TTM)-
  • Revenue (TTM)52.61M
  • Gross Margin (TTM)85.74%
  • Net Margin (TTM)-32.99%
  • Debt To Equity (MRQ)-355.07%

EVENTS

  • Earnings Date10/26/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Alimera Sciences Inc

 

Profile

MORE
Alimera Sciences, Inc. is a pharmaceutical company. The Company is engaged in commercialization and development of prescription ophthalmic pharmaceuticals. The Company focuses on diseases affecting the retina. The Company’s commercial product, ILUVIEN, is an intravitreal implant that treats patients by delivering a continuous microdose of the corticosteroid fluocinolone acetonide (FAc) in the eye, for up to 36 months. The Company’s product ILUVIEN is also used for the...
C. Daniel Myers
Non-Executive Chairman of the Board
Richard Eiswirth Jr.
President, Chief Executive Officer, Director
Philip Ashman Ph.D.
Chief Operating Officer, Senior Vice President - Commercial Operations Europe
J. Phillip Jones CPA
Chief Financial Officer
Address
STE 290, 6120 WINDWARD PARKWAY
Alpharetta, GA
30005
United States

Top Peers

SYMBOLLASTCHG%CHG
MEIP
MEI Pharma Inc
0.3866-0.0145-3.6151%
AQST
Aquestive Therapeutics Inc
1.17+0.05+4.46%
CPIX
Cumberland Pharmaceuticals Inc
2.41-0.08-3.21%
CASI
CASI Pharmaceuticals Inc
2.60-0.08-2.99%
AZYO
Aziyo Biologics Inc
7.20+0.50+7.46%